동물 신경변성질환 진단 시장 규모, 점유율, 동향 분석 보고서 : 동물 유형별, 유형별, 적응증별, 진단 검사별, 최종 용도별, 지역별, 부문 예측(2025-2030년)

Veterinary Neurodegenerative Disease Diagnostics Market Growth & Trends:

The global veterinary neurodegenerative disease diagnostics market size is anticipated to reach USD 596.1 million by 2030 and is projected to grow at a CAGR of 8.69% from 2025 to 2030, according to a new report by Grand View Research, Inc. Several factors are responsible for the market growth.

Firstly, the rising pet ownership globally has increased demand for advanced veterinary care, including neurodegenerative diagnostics and treatments. Secondly, the growing awareness among pet owners about age-related neurological conditions, such as canine cognitive dysfunction, is driving early diagnosis and intervention. Thirdly, advancements in veterinary imaging and biomarker diagnostics are enabling accurate and non-invasive detection of neurodegenerative diseases. In addition, increased research and development activities in veterinary neuroscience, along with the availability of novel therapeutics and neuroprotective drugs, are expanding treatment options. The trend of pet humanization, where animals are treated as family members, further encourages spending on specialized healthcare services. Lastly, supportive government and private initiatives to improve animal health infrastructure and services are also boosting market growth.

The increasing number of veterinarians contributes significantly to the market by expanding access to specialized care and early diagnosis of neurological disorders in animals. For instance, according to AVMA, the number of veterinarians increased to 130,415 in 2024 from 127,131 in 2023. As more veterinary professionals enter the field, especially those trained in neurology, the availability of advanced services such as neuroimaging, biomarker testing, and tailored treatment plans rises. This not only improves the quality of care but also boosts pet owners' confidence in seeking early medical attention for symptoms like seizures, behavioral changes, or mobility issues. Moreover, a larger veterinary workforce facilitates the adoption of cutting-edge technologies and therapies, thereby accelerating market expansion through enhanced service capacity and outreach.

Moreover, strategic initiatives by key players are significantly driving the market growth by fostering innovation, expanding market reach, and improving diagnostic capabilities. For instance, in October 2024, WOORIEN Co., Ltd, a specialist in veterinary imaging equipment and solutions, launched 'MyVet CT Plus.' Designed to accommodate a wide range of animal sizes from small lizards to large retrievers, MyVet CT Plus offers significantly faster imaging with improved quality. Compared to its predecessor, it reduces acquisition time by at least 45%, with potential reductions of up to 80%.

Veterinary Neurodegenerative Disease Diagnostics Market Report Highlights:

• The consumables, reagents, and kits segment accounted for the largest market revenue share in 2024. These products support veterinarians in conducting advanced molecular and biochemical tests, which are essential for diagnosing complex neurodegenerative diseases that are challenging to identify based solely on clinical symptoms.
• The companion segment dominated accounted for the largest market revenue share in 2024. This segment is also anticipated to grow at the fastest CAGR over the forecast period.
• The imaging segment accounted for the largest market revenue share in 2024, driven by its vital role in the early and accurate diagnosis of neurological disorders in animals.
• The cognitive dysfunction segment led the market with the largest revenue share of 40.35% in 2024, driven by its high prevalence in companion animals and the critical need for rapid and accurate detection to prevent outbreaks.
• Veterinary hospitals and clinics hold a dominant position in the global market, as they are the primary locations where animals receive their initial assessment and diagnosis.
• North America dominated the market with the largest revenue share of 38.25% in 2024, while the Asia Pacific region is projected to experience at the fastest CAGR during the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased Database
  • 1.3.2. GVR's Internal Database
  • 1.3.3. Secondary Sources
  • 1.3.4. Primary Research
• 1.4. Information/Data Analysis
• 1.5. Market Formulation & Visualization
• 1.6. Data Validation & Publishing
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis
  • 1.7.2. Global Market: CAGR Calculation
• 1.8. List of Secondary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Veterinary Neurodegenerative Disease Diagnostics Market Variable Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market
  • 3.1.2. Ancillary Market
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing prevalence of neurodegenerative diseases in companion animals
    • 3.2.1.2. Rising medicalization rate
    • 3.2.1.3. Increasing pet health expenditure
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Lack of standardized regulations
    • 3.2.2.2. Lack of awareness in developing economies
  • 3.2.3. Market Opportunity Analysis
  • 3.2.4. Market Challenge Analysis
• 3.3. Veterinary Neurodegenerative Disease Diagnostics Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitution
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal landscape
    • 3.3.2.2. Economic and Social landscape
    • 3.3.2.3. Technological landscape
    • 3.3.2.4. Environmental landscape
  • 3.3.3. Regulatory Framework
  • 3.3.4. Pricing Analysis
  • 3.3.5. Pet ownership Demographics
  • 3.3.6. Estimated Animal Population by key countries, key species, 2024

Chapter 4. Veterinary Neurodegenerative Disease Diagnostics Market: Animal Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Veterinary Neurodegenerative Disease Diagnostics Market: Animal type Movement Analysis
• 4.3. Veterinary Neurodegenerative Disease Diagnostics Market Size & Trend Analysis, by animal type, 2018 to 2030 (USD Million)
• 4.4. Livestock
  • 4.4.1. Livestock Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.2. Sheep
    • 4.4.2.1. Sheep Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.3. Cattle
    • 4.4.3.1. Cattle Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.4. Others
    • 4.4.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. Companion
  • 4.5.1. Companion Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.2. Canine
    • 4.5.2.1. Canine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.3. Feline
    • 4.5.3.1. Feline Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.4. Equine
    • 4.5.4.1. Equine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.5. Others
    • 4.5.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Veterinary Neurodegenerative Disease Diagnostics Market: Diagnostic Tests Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Veterinary Neurodegenerative Disease Diagnostics Market: Diagnostic Tests Movement Analysis
• 5.3. Veterinary Neurodegenerative Disease Diagnostics Market Size & Trend Analysis, by Diagnostic Tests, 2018 to 2030 (USD Million)
• 5.4. Imaging
  • 5.4.1. Imaging Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4.2. MRI (Magnetic Resonance Imaging)
    • 5.4.2.1. MRI (Magnetic Resonance Imaging) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4.3. CT (Computed Tomography)
    • 5.4.3.1. CT (Computed Tomography) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4.4. Others
    • 5.4.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.5. Biomarker Diagnostic Tests
  • 5.5.1. Biomarker Diagnostic Tests Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.2. CSF (Cerebrospinal Fluid) biomarkers
    • 5.5.2.1. CSF (Cerebrospinal Fluid) biomarkers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.3. Blood-based biomarkers
    • 5.5.3.1. Blood-based biomarkers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.4. Others
    • 5.5.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Others
  • 5.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Veterinary Neurodegenerative Disease Diagnostics Market: By Product Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Veterinary Neurodegenerative Disease Diagnostics Market: By Product Movement Analysis
• 6.3. Veterinary Neurodegenerative Disease Diagnostics Market Size & Trend Analysis, by product, 2018 to 2030 (USD Million)
  • 6.3.1. Consumables, Reagents & Kits
    • 6.3.1.1. Consumables, Reagents & Kits Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.2. Equipment & Instruments
    • 6.3.2.1. Equipment & Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Veterinary Neurodegenerative Disease Diagnostics Market: By Indication Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Veterinary Neurodegenerative Disease Diagnostics Market: By Indication Movement Analysis
• 7.3. Veterinary Neurodegenerative Disease Diagnostics Market Size & Trend Analysis, by Indication, 2018 to 2030 (USD Million)
  • 7.3.1. Cognitive Dysfunction
    • 7.3.1.1. Cognitive Dysfunction Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3.2. Cerebellar Abiotrophy
    • 7.3.2.1. Cerebellar Abiotrophy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3.3. Spongiform Encephalopathies
    • 7.3.3.1. Spongiform Encephalopathies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3.4. Others
    • 7.3.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Veterinary Neurodegenerative Disease Diagnostics Market: By End Use Estimates & Trend Analysis

• 8.1. Segment Dashboard
• 8.2. Veterinary Neurodegenerative Disease Diagnostics Market: By End Use Movement Analysis
• 8.3. Veterinary Neurodegenerative Disease Diagnostics Market Size & Trend Analysis, by End use, 2018 to 2030 (USD Million)
  • 8.3.1. Veterinary Hospitals and Clinics
    • 8.3.1.1. Veterinary Hospitals and Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3.2. Veterinary Diagnostic Laboratories
    • 8.3.2.1. Veterinary Diagnostic Laboratories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3.3. Others
    • 8.3.3.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Veterinary Neurodegenerative Disease Diagnostics Market: Regional Estimates & Trend Analysis

• 9.1. Regional Dashboard
• 9.2. Veterinary Neurodegenerative Disease Diagnostics Market Share, By Region, 2024 & 2030, USD Million
• 9.3. Regional Outlook
• 9.4. North America
  • 9.4.1. North America Veterinary Neurodegenerative Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.4.2. U.S.
    • 9.4.2.1. Key Country Dynamics
    • 9.4.2.2. U.S. Veterinary Neurodegenerative Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.4.3. Canada
    • 9.4.3.1. Key Country Dynamics
    • 9.4.3.2. Canada Veterinary Neurodegenerative Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.4.4. Mexico
    • 9.4.4.1. Key Country Dynamics
    • 9.4.4.2. Mexico Veterinary Neurodegenerative Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 9.5. Europe
  • 9.5.1. Europe Veterinary Neurodegenerative Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5.2. UK
    • 9.5.2.1. Key Country Dynamics
    • 9.5.2.2. UK Veterinary Neurodegenerative Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5.3. Germany
    • 9.5.3.1. Key Country Dynamics
    • 9.5.3.2. Germany Veterinary Neurodegenerative Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5.4. France
    • 9.5.4.1. Key Country Dynamics
    • 9.5.4.2. France Veterinary Neurodegenerative Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5.5. Italy
    • 9.5.5.1. Key Country Dynamics
    • 9.5.5.2. Italy Veterinary Neurodegenerative Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5.6. Spain
    • 9.5.6.1. Key Country Dynamics
    • 9.5.6.2. Spain Veterinary Neurodegenerative Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5.7. Denmark
    • 9.5.7.1. Key Country Dynamics
    • 9.5.7.2. Denmark Veterinary Neurodegenerative Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5.8. Sweden
    • 9.5.8.1. Key Country Dynamics
    • 9.5.8.2. Sweden Veterinary Neurodegenerative Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5.9. Norway
    • 9.5.9.1. Key Country Dynamics
    • 9.5.9.2. Norway Veterinary Neurodegenerative Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 9.6. Asia Pacific
  • 9.6.1. Asia Pacific Veterinary Neurodegenerative Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.6.2. Japan
    • 9.6.2.1. Key Country Dynamics
    • 9.6.2.2. Japan Veterinary Neurodegenerative Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.6.3. China
    • 9.6.3.1. Key Country Dynamics
    • 9.6.3.2. China Veterinary Neurodegenerative Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.6.4. India
    • 9.6.4.1. Key Country Dynamics
    • 9.6.4.2. India Veterinary Neurodegenerative Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.6.5. Australia
    • 9.6.5.1. Key Country Dynamics
    • 9.6.5.2. Australia Veterinary Neurodegenerative Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.6.6. South Korea
    • 9.6.6.1. Key Country Dynamics
    • 9.6.6.2. South Korea Veterinary Neurodegenerative Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.6.7. Thailand
    • 9.6.7.1. Key Country Dynamics
    • 9.6.7.2. Thailand Veterinary Neurodegenerative Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 9.7. Latin America
  • 9.7.1. Latin America Veterinary Neurodegenerative Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.7.2. Brazil
    • 9.7.2.1. Key Country Dynamics
    • 9.7.2.2. Brazil Veterinary Neurodegenerative Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.7.3. Argentina
    • 9.7.3.1. Key Country Dynamics
    • 9.7.3.2. Argentina Veterinary Neurodegenerative Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 9.8. Middle East & Africa
  • 9.8.1. Middle East & Africa Veterinary Neurodegenerative Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.8.2. South Africa
    • 9.8.2.1. Key Country Dynamics
    • 9.8.2.2. South Africa Veterinary Neurodegenerative Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.8.3. Saudi Arabia
    • 9.8.3.1. Key Country Dynamics
    • 9.8.3.2. Saudi Arabia Veterinary Neurodegenerative Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.8.4. UAE
    • 9.8.4.1. Key Country Dynamics
    • 9.8.4.2. UAE Veterinary Neurodegenerative Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.8.5. Kuwait
    • 9.8.5.1. Key Country Dynamics
    • 9.8.5.2. Kuwait Veterinary Neurodegenerative Disease Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

• 10.1. Market Participant Categorization
• 10.2. Company Market Position Analysis/ Heap Map Analysis
• 10.3. Company Profiles
  • 10.3.1. Zoetis Services LLC.
    • 10.3.1.1. Participant's Overview
    • 10.3.1.2. Financial Performance
    • 10.3.1.3. Product Benchmarking
    • 10.3.1.4. Strategic Initiatives
  • 10.3.2. Virbac.
    • 10.3.2.1. Participant's Overview
    • 10.3.2.2. Financial Performance
    • 10.3.2.3. Product Benchmarking
    • 10.3.2.4. Strategic Initiatives
  • 10.3.3. Life Diagnostics.
    • 10.3.3.1. Participant's Overview
    • 10.3.3.2. Financial Performance
    • 10.3.3.3. Product Benchmarking
    • 10.3.3.4. Strategic Initiatives
  • 10.3.4. ACUVET BIOTECH
    • 10.3.4.1. Participant's Overview
    • 10.3.4.2. Financial Performance
    • 10.3.4.3. Product Benchmarking
    • 10.3.4.4. Strategic Initiatives
  • 10.3.5. Merck & Co., Inc.
    • 10.3.5.1. Participant's Overview
    • 10.3.5.2. Financial Performance
    • 10.3.5.3. Product Benchmarking
    • 10.3.5.4. Strategic Initiatives
  • 10.3.6. IDEXX Laboratories, Inc.
    • 10.3.6.1. Participant's Overview
    • 10.3.6.2. Financial Performance
    • 10.3.6.3. Product Benchmarking
    • 10.3.6.4. Strategic Initiatives
  • 10.3.7. MI: RNA Diagnostics Ltd.
    • 10.3.7.1. Participant's Overview
    • 10.3.7.2. Financial Performance
    • 10.3.7.3. Product Benchmarking
    • 10.3.7.4. Strategic Initiatives
  • 10.3.8. Mercodia AB
    • 10.3.8.1. Participant's Overview
    • 10.3.8.2. Financial Performance
    • 10.3.8.3. Product Benchmarking
    • 10.3.8.4. Strategic Initiatives
  • 10.3.9. Antech Diagnostics, Inc.
    • 10.3.9.1. Participant's Overview
    • 10.3.9.2. Financial Performance
    • 10.3.9.3. Product Benchmarking
    • 10.3.9.4. Strategic Initiatives
  • 10.3.10. Avacta Animal Health Limited Participant's Overview
    • 10.3.10.1. Participant's Overview
    • 10.3.10.2. Financial Performance
    • 10.3.10.3. Product Benchmarking
    • 10.3.10.4. Strategic Initiatives
• 10.4. Strategy Mapping
  • 10.4.1. Mergers & Acquisitions
  • 10.4.2. Partnerships & Collaborations
  • 10.4.3. Product launch
  • 10.4.4. Others
• 10.5. List of other key players